CG
VIVO

Cutler Group’s Meridian Bioscience Inc VIVO Stock Holding History

Cutler Group’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-4,000
Closed -$2K – 7470
2016
Q4 		$2K Sell
4,000
-1,000
-20% -$17.6K ﹤0.01% 5760
2016
Q3 		$1K Buy
5,000
+1,000
+25% +$19.6K ﹤0.01% 6389
2016
Q2 		$2K Buy
+4,000
New +$78.4K ﹤0.01% 5823

Other funds holding VIVO

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Cutler Group's VIVO Position: Q2 2017 in Review

Cutler Group sold out of Meridian Bioscience Inc (VIVO) in Q2 2017, closing a stake of 1,000 shares — an estimated $14.4K sold.

Cutler Group first reported a position in VIVO in Q4 2015 and held it in 5 quarters. The position peaked at $48K in Q4 2015. 170 funds tracked by Wall St. Rank hold VIVO as of Q2 2017.

  • Cutler Group reported no remaining Meridian Bioscience Inc position as of Q2 2017 after selling out during the quarter.
  • Cutler Group sold 1,000 Meridian Bioscience Inc shares in Q2 2017, an estimated $14.4K.
  • Cutler Group first reported a position in Meridian Bioscience Inc in Q4 2015 and held it in 5 quarters.
  • Cutler Group's Meridian Bioscience Inc position peaked at $48K in Q4 2015.
  • 170 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2017.

Based on Cutler Group's 13F filing for Q2 2017, filed 11 Jul 2017.